KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Acquisitions (2021 - 2024)

Historic Acquisitions for Cardlytics (CDLX) over the last 3 years, with Q4 2024 value amounting to $202000.0.

  • Cardlytics' Acquisitions changed N/A to $202000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $202000.0, marking a year-over-year change of. This contributed to the annual value of $2.3 million for FY2022, which is 9953.98% down from last year.
  • Latest data reveals that Cardlytics reported Acquisitions of $202000.0 as of Q4 2024.
  • In the past 5 years, Cardlytics' Acquisitions registered a high of $494.1 million during Q2 2021, and its lowest value of $202000.0 during Q4 2024.
  • Moreover, its 3-year median value for Acquisitions was $75.5 million (2021), whereas its average is $161.3 million.
  • Within the past 5 years, the most significant YoY rise in Cardlytics' Acquisitions was 9847.01% (2022), while the steepest drop was 9847.01% (2022).
  • Over the past 3 years, Cardlytics' Acquisitions (Quarter) stood at $494.1 million in 2021, then tumbled by 99.54% to $2.3 million in 2022, then crashed by 91.12% to $202000.0 in 2024.
  • Its Acquisitions stands at $202000.0 for Q4 2024, versus $2.3 million for Q1 2022 and $494.1 million for Q2 2021.